Ann Dermatol.  2019 Jun;31(3):347-348. 10.5021/ad.2019.31.3.347.

Alitretinoin Treatment for Gefitinib-Induced Paronychia

Affiliations
  • 1Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul, Korea. lyb80@catholic.ac.kr

Abstract

No abstract available.


MeSH Terms

Paronychia*

Figure

  • Fig. 1 The patient showed substantial improvement of hand eczema, paronychia and onychodystrophy after six months of treatment.


Reference

1. Agero AL, Dusza SW, Benvenuto-Andrade C, Busam KJ, Myskowski P, Halpern AC. Dermatologic side effects associated with the epidermal growth factor receptor inhibitors. J Am Acad Dermatol. 2006; 55:657–670.
Article
2. Alsenaid A, Eder I, Ruzicka T, Braun-Falco M, Wolf R. Successful treatment of nail lichen planus with alitretinoin: report of 2 cases and review of the literature. Dermatology. 2014; 229:293–296.
Article
3. Iorizzo M. Nail lichen planus-a possible new indication for oral alitretinoin. J Eur Acad Dermatol Venereol. 2016; 30:509–510.
Article
4. Milanesi N, D'Erme AM, Gola M. Nail improvement during alitretinoin treatment: three case reports and review of the literature. Clin Exp Dermatol. 2015; 40:533–536.
Article
5. Figueiras Dde A, Ramos TB, Marinho AK, Bezerra MS, Cauas RC. Paronychia and granulation tissue formation during treatment with isotretinoin. An Bras Dermatol. 2016; 91:223–225.
Article
Full Text Links
  • AD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr